HEADER NUCLEAR TRANSPORT 22-APR-02 1GYB TITLE N77Y POINT MUTANT OF YNTF2 BOUND TO FXFG NUCLEOPORIN REPEAT COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR TRANSPORT FACTOR 2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: NTF-2, NUCLEAR TRANSPORT FACTOR P10; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NUCLEOPORIN; COMPND 9 CHAIN: E, F, G, H; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630 KEYWDS NUCLEAR TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR R.BAYLISS,M.STEWART REVDAT 4 08-MAY-24 1GYB 1 REMARK REVDAT 3 21-DEC-16 1GYB 1 SOURCE REMARK VERSN FORMUL REVDAT 2 24-FEB-09 1GYB 1 VERSN REVDAT 1 20-JUN-02 1GYB 0 JRNL AUTH R.BAYLISS,S.LEUNG,R.BAKER,B.QUIMBY,A.CORBETT,M.STEWART JRNL TITL STRUCTURAL BASIS FOR THE INTERACTION BETWEEN NTF2 AND JRNL TITL 2 NUCLEOPORIN FXFG REPEATS JRNL REF EMBO J. V. 21 2843 2002 JRNL REFN ISSN 0261-4189 JRNL PMID 12065398 JRNL DOI 10.1093/EMBOJ/CDF305 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 39224 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SAME AS XXX REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4091 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 384 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.420 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GYB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-APR-02. REMARK 100 THE DEPOSITION ID IS D_1290009644. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39224 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 53.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.25700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM AMMONIUM ACETATE PH 6.5, 1.6M REMARK 280 AMMONIUM SULPHATE, PH 6.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.03000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ALA A 125 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 ALA B 125 REMARK 465 MET C 1 REMARK 465 SER C 2 REMARK 465 LEU C 3 REMARK 465 ASP C 4 REMARK 465 ALA C 125 REMARK 465 MET D 1 REMARK 465 SER D 2 REMARK 465 LEU D 3 REMARK 465 ASP D 4 REMARK 465 ALA D 125 REMARK 465 ASP E 40 REMARK 465 SER E 41 REMARK 465 SER E 47 REMARK 465 LYS E 48 REMARK 465 ASP F 40 REMARK 465 SER F 41 REMARK 465 GLY F 42 REMARK 465 GLY F 46 REMARK 465 SER F 47 REMARK 465 LYS F 48 REMARK 465 ASP G 40 REMARK 465 SER G 41 REMARK 465 GLY G 46 REMARK 465 SER G 47 REMARK 465 LYS G 48 REMARK 465 ASP H 40 REMARK 465 SER H 41 REMARK 465 GLY H 42 REMARK 465 GLY H 46 REMARK 465 SER H 47 REMARK 465 LYS H 48 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 3 CG CD1 CD2 REMARK 470 ASN A 110 CG OD1 ND2 REMARK 470 GLU C 92 CG CD OE1 OE2 REMARK 470 GLU C 93 CG CD OE1 OE2 REMARK 470 PHE D 5 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN D 94 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE G 43 N - CA - C ANGL. DEV. = 19.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 40 -112.30 55.96 REMARK 500 PRO A 58 19.60 -66.19 REMARK 500 ASP A 91 -137.36 54.46 REMARK 500 ASP B 4 -61.73 -103.09 REMARK 500 ASP B 23 93.71 -170.97 REMARK 500 THR B 41 -20.50 79.23 REMARK 500 SER B 111 -157.88 -123.76 REMARK 500 TYR B 123 132.25 -39.87 REMARK 500 ASP C 23 96.65 -164.16 REMARK 500 GLU C 40 -114.54 58.76 REMARK 500 PRO C 58 -6.41 -57.91 REMARK 500 ASP C 91 -125.45 47.43 REMARK 500 ASN C 95 99.00 -48.17 REMARK 500 SER C 111 -142.03 -142.94 REMARK 500 ASN D 6 74.27 47.47 REMARK 500 GLU D 40 -120.80 57.09 REMARK 500 ASP D 91 -105.79 48.79 REMARK 500 GLU D 92 27.33 -147.76 REMARK 500 GLN D 94 -96.31 -31.87 REMARK 500 PHE G 43 169.81 -18.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GY5 RELATED DB: PDB REMARK 900 D92N,D94N DOUBLE POINT MUTANT OF HUMAN NUCLEAR TRANSPORT FACTOR 2 REMARK 900 (NTF2) REMARK 900 RELATED ID: 1GY6 RELATED DB: PDB REMARK 900 NTF2 FROM RAT, AMMONIUM SULPHATE CONDITIONS REMARK 900 RELATED ID: 1GY7 RELATED DB: PDB REMARK 900 N77Y POINT MUTANT OF S.CEREVISIAE NTF2 DBREF 1GYB A 1 125 UNP P33331 NTF2_YEAST 1 125 DBREF 1GYB B 1 125 UNP P33331 NTF2_YEAST 1 125 DBREF 1GYB C 1 125 UNP P33331 NTF2_YEAST 1 125 DBREF 1GYB D 1 125 UNP P33331 NTF2_YEAST 1 125 DBREF 1GYB E 40 48 PDB 1GYB 1GYB 40 48 DBREF 1GYB F 40 48 PDB 1GYB 1GYB 40 48 DBREF 1GYB G 40 48 PDB 1GYB 1GYB 40 48 DBREF 1GYB H 40 48 PDB 1GYB 1GYB 40 48 SEQADV 1GYB TYR A 77 UNP P33331 ASN 77 ENGINEERED MUTATION SEQADV 1GYB TYR B 77 UNP P33331 ASN 77 ENGINEERED MUTATION SEQADV 1GYB TYR C 77 UNP P33331 ASN 77 ENGINEERED MUTATION SEQADV 1GYB TYR D 77 UNP P33331 ASN 77 ENGINEERED MUTATION SEQRES 1 A 125 MET SER LEU ASP PHE ASN THR LEU ALA GLN ASN PHE THR SEQRES 2 A 125 GLN PHE TYR TYR ASN GLN PHE ASP THR ASP ARG SER GLN SEQRES 3 A 125 LEU GLY ASN LEU TYR ARG ASN GLU SER MET LEU THR PHE SEQRES 4 A 125 GLU THR SER GLN LEU GLN GLY ALA LYS ASP ILE VAL GLU SEQRES 5 A 125 LYS LEU VAL SER LEU PRO PHE GLN LYS VAL GLN HIS ARG SEQRES 6 A 125 ILE THR THR LEU ASP ALA GLN PRO ALA SER PRO TYR GLY SEQRES 7 A 125 ASP VAL LEU VAL MET ILE THR GLY ASP LEU LEU ILE ASP SEQRES 8 A 125 GLU GLU GLN ASN PRO GLN ARG PHE SER GLN VAL PHE HIS SEQRES 9 A 125 LEU ILE PRO ASP GLY ASN SER TYR TYR VAL PHE ASN ASP SEQRES 10 A 125 ILE PHE ARG LEU ASN TYR SER ALA SEQRES 1 B 125 MET SER LEU ASP PHE ASN THR LEU ALA GLN ASN PHE THR SEQRES 2 B 125 GLN PHE TYR TYR ASN GLN PHE ASP THR ASP ARG SER GLN SEQRES 3 B 125 LEU GLY ASN LEU TYR ARG ASN GLU SER MET LEU THR PHE SEQRES 4 B 125 GLU THR SER GLN LEU GLN GLY ALA LYS ASP ILE VAL GLU SEQRES 5 B 125 LYS LEU VAL SER LEU PRO PHE GLN LYS VAL GLN HIS ARG SEQRES 6 B 125 ILE THR THR LEU ASP ALA GLN PRO ALA SER PRO TYR GLY SEQRES 7 B 125 ASP VAL LEU VAL MET ILE THR GLY ASP LEU LEU ILE ASP SEQRES 8 B 125 GLU GLU GLN ASN PRO GLN ARG PHE SER GLN VAL PHE HIS SEQRES 9 B 125 LEU ILE PRO ASP GLY ASN SER TYR TYR VAL PHE ASN ASP SEQRES 10 B 125 ILE PHE ARG LEU ASN TYR SER ALA SEQRES 1 C 125 MET SER LEU ASP PHE ASN THR LEU ALA GLN ASN PHE THR SEQRES 2 C 125 GLN PHE TYR TYR ASN GLN PHE ASP THR ASP ARG SER GLN SEQRES 3 C 125 LEU GLY ASN LEU TYR ARG ASN GLU SER MET LEU THR PHE SEQRES 4 C 125 GLU THR SER GLN LEU GLN GLY ALA LYS ASP ILE VAL GLU SEQRES 5 C 125 LYS LEU VAL SER LEU PRO PHE GLN LYS VAL GLN HIS ARG SEQRES 6 C 125 ILE THR THR LEU ASP ALA GLN PRO ALA SER PRO TYR GLY SEQRES 7 C 125 ASP VAL LEU VAL MET ILE THR GLY ASP LEU LEU ILE ASP SEQRES 8 C 125 GLU GLU GLN ASN PRO GLN ARG PHE SER GLN VAL PHE HIS SEQRES 9 C 125 LEU ILE PRO ASP GLY ASN SER TYR TYR VAL PHE ASN ASP SEQRES 10 C 125 ILE PHE ARG LEU ASN TYR SER ALA SEQRES 1 D 125 MET SER LEU ASP PHE ASN THR LEU ALA GLN ASN PHE THR SEQRES 2 D 125 GLN PHE TYR TYR ASN GLN PHE ASP THR ASP ARG SER GLN SEQRES 3 D 125 LEU GLY ASN LEU TYR ARG ASN GLU SER MET LEU THR PHE SEQRES 4 D 125 GLU THR SER GLN LEU GLN GLY ALA LYS ASP ILE VAL GLU SEQRES 5 D 125 LYS LEU VAL SER LEU PRO PHE GLN LYS VAL GLN HIS ARG SEQRES 6 D 125 ILE THR THR LEU ASP ALA GLN PRO ALA SER PRO TYR GLY SEQRES 7 D 125 ASP VAL LEU VAL MET ILE THR GLY ASP LEU LEU ILE ASP SEQRES 8 D 125 GLU GLU GLN ASN PRO GLN ARG PHE SER GLN VAL PHE HIS SEQRES 9 D 125 LEU ILE PRO ASP GLY ASN SER TYR TYR VAL PHE ASN ASP SEQRES 10 D 125 ILE PHE ARG LEU ASN TYR SER ALA SEQRES 1 E 9 ASP SER GLY PHE SER PHE GLY SER LYS SEQRES 1 F 9 ASP SER GLY PHE SER PHE GLY SER LYS SEQRES 1 G 9 ASP SER GLY PHE SER PHE GLY SER LYS SEQRES 1 H 9 ASP SER GLY PHE SER PHE GLY SER LYS FORMUL 9 HOH *384(H2 O) HELIX 1 1 ASP A 4 ARG A 24 1 21 HELIX 2 2 SER A 25 ASN A 29 5 5 HELIX 3 3 GLY A 46 LEU A 57 1 12 HELIX 4 4 ASP B 4 ARG B 24 1 21 HELIX 5 5 SER B 25 ASN B 29 5 5 HELIX 6 6 GLY B 46 LEU B 57 1 12 HELIX 7 7 PHE C 5 ARG C 24 1 20 HELIX 8 8 SER C 25 ASN C 29 5 5 HELIX 9 9 GLY C 46 LEU C 57 1 12 HELIX 10 10 ASN D 6 ARG D 24 1 19 HELIX 11 11 SER D 25 ASN D 29 5 5 HELIX 12 12 GLY D 46 LEU D 57 1 12 SHEET 1 AA 6 SER A 42 GLN A 45 0 SHEET 2 AA 6 TYR A 31 PHE A 39 -1 O LEU A 37 N LEU A 44 SHEET 3 AA 6 SER A 111 ASN A 122 1 O VAL A 114 N ARG A 32 SHEET 4 AA 6 GLN A 97 ASP A 108 -1 O ARG A 98 N ASN A 122 SHEET 5 AA 6 VAL A 80 ILE A 90 -1 O VAL A 80 N LEU A 105 SHEET 6 AA 6 VAL A 62 PRO A 73 -1 O GLN A 63 N LEU A 89 SHEET 1 BA 6 SER B 42 GLN B 45 0 SHEET 2 BA 6 TYR B 31 PHE B 39 -1 O LEU B 37 N LEU B 44 SHEET 3 BA 6 SER B 111 LEU B 121 1 O VAL B 114 N ARG B 32 SHEET 4 BA 6 GLN B 97 ASP B 108 -1 O SER B 100 N ARG B 120 SHEET 5 BA 6 VAL B 80 ILE B 90 -1 O VAL B 80 N LEU B 105 SHEET 6 BA 6 VAL B 62 PRO B 73 -1 O GLN B 63 N LEU B 89 SHEET 1 CA 6 SER C 42 GLN C 45 0 SHEET 2 CA 6 TYR C 31 PHE C 39 -1 O LEU C 37 N LEU C 44 SHEET 3 CA 6 SER C 111 ASN C 122 1 O VAL C 114 N ARG C 32 SHEET 4 CA 6 GLN C 97 ASP C 108 -1 O ARG C 98 N ASN C 122 SHEET 5 CA 6 VAL C 80 ILE C 90 -1 O VAL C 80 N LEU C 105 SHEET 6 CA 6 VAL C 62 PRO C 73 -1 O GLN C 63 N LEU C 89 SHEET 1 DA 6 SER D 42 GLN D 45 0 SHEET 2 DA 6 TYR D 31 PHE D 39 -1 O LEU D 37 N LEU D 44 SHEET 3 DA 6 SER D 111 LEU D 121 1 O VAL D 114 N ARG D 32 SHEET 4 DA 6 GLN D 97 ASP D 108 -1 O SER D 100 N ARG D 120 SHEET 5 DA 6 VAL D 80 ILE D 90 -1 O VAL D 80 N LEU D 105 SHEET 6 DA 6 VAL D 62 PRO D 73 -1 O GLN D 63 N LEU D 89 CRYST1 58.840 84.060 61.790 90.00 116.00 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016995 0.000000 0.008289 0.00000 SCALE2 0.000000 0.011896 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018006 0.00000